Related Experiment Video
Updated: May 12, 2026
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
Strategies to reverse melanoma-induced T-cell dysfunction
Julien Fourcade1, Hassane M Zarour
1Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Abstract:
Patients with advanced melanoma can develop spontaneous cellular and humoral responses to tumor antigens. Understanding the failure of spontaneous or vaccine-induced tumor antigen-specific T-cell responses to promote the immunologic clearance of melanomas is critical. Multiple mechanisms of melanoma-induced immune escape, which are likely to cause the failure of the spontaneous or vaccine-induced immune responses to promote tumor regression in humans, have been elucidated. In addition, a number of negative factors in the tumor microenvironment dampen antitumor immune responses, including cytokines (like transforming growth factor-β or interleukin-10), suppressive cells (regulatory T cells and myelosuppressive dendritic cells), defective antigen presentation by tumor cells (human leukocyte antigen or T antigen expression loss, antigen processing machinery defects), amino acid catabolizing enzymes (indoleamine-2-3 dioxygenase, arginase), and immune inhibitory pathways (like cytotoxic T-lymphocyte antigen 4/cluster of differentiation 28, programmed death 1/programmed death 1 ligand 1). This information has been used to develop a number of therapies to specifically target these negative regulators of antimelanoma immune responses to enhance tumor antigen-specific immune responses and to increase the likelihood of clinical benefits in patients with advanced melanoma.
Insights
Understanding why melanoma immune responses fail is key to developing effective cancer treatments. Targeting immune escape mechanisms can enhance T-cell responses and improve clinical outcomes for advanced melanoma patients.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Advanced melanoma patients exhibit spontaneous immune responses to tumor antigens.
- Understanding the failure of these immune responses is critical for effective treatment.
- Melanoma employs various immune escape mechanisms that hinder tumor regression.
Purpose of the Study:
- To elucidate the mechanisms of melanoma-induced immune escape.
- To identify factors within the tumor microenvironment that suppress antitumor immunity.
- To inform the development of novel therapies targeting these suppressive elements.
Main Methods:
- Review and synthesis of existing research on melanoma immunology and immune escape.
- Analysis of suppressive factors in the tumor microenvironment, including cytokines, suppressive cells, and immune checkpoints.
- Identification of defects in antigen presentation and processing by melanoma cells.
Main Results:
- Multiple melanoma immune escape mechanisms have been identified.
- Key suppressive factors in the tumor microenvironment include TGF-β, IL-10, regulatory T cells, MDSCs, and immune checkpoints (CTLA-4, PD-1/PD-L1).
- Defective antigen presentation and amino acid catabolizing enzymes (IDO, arginase) contribute to immune suppression.
Conclusions:
- Targeting identified immune escape mechanisms and suppressive microenvironment factors is crucial.
- Therapies aimed at enhancing tumor antigen-specific T-cell responses hold promise.
- These strategies can potentially increase clinical benefits for patients with advanced melanoma.
Related Concept Videos
01:27Tumor Immunotherapy
02:17The Tumor Microenvironment
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:40Cell-mediated Immune Responses